Azacitidine
Common brands: Vidaza, Onureg, Azacitidine Azacitidine, Venclexta, Allopurinol
Top reporter: Celgene Corporation
Nucleoside Metabolic Inhibitor [EPC]BCL-2 Inhibitor [EPC]Azole Antifungal [EPC]Xanthine Oxidase Inhibitor [EPC]Corticosteroid [EPC]
28,768
Total Reports
19,084
Serious Reports
10,593
Death Reports
30
Reported Reactions
Death Report Ratio: High (36.82%)
Patient Demographics
Reported Adverse Reactions (30)
Side effects reported in FDA adverse event reports for Azacitidine.
| # | Reaction | Reports | % of Total |
|---|---|---|---|
| 1 | DEATH | 3,318 | |
| 2 | FEBRILE NEUTROPENIA | 2,894 | |
| 3 | ACUTE MYELOID LEUKAEMIA | 2,164 | |
| 4 | PNEUMONIA | 1,964 | |
| 5 | OFF LABEL USE | 1,938 | |
| 6 | NEUTROPENIA | 1,850 | |
| 7 | PYREXIA | 1,608 | |
| 8 | THROMBOCYTOPENIA | 1,508 | |
| 9 | MYELOSUPPRESSION | 1,467 | |
| 10 | ANAEMIA | 1,318 | |
| 11 | SEPSIS | 1,230 | |
| 12 | PLATELET COUNT DECREASED | 1,209 | |
| 13 | DRUG INEFFECTIVE | 1,177 | |
| 14 | INFECTION | 1,084 | |
| 15 | PANCYTOPENIA | 1,020 | |
| 16 | NAUSEA | 996 | |
| 17 | WHITE BLOOD CELL COUNT DECREASED | 960 | |
| 18 | DIARRHOEA | 864 | |
| 19 | NEUTROPHIL COUNT DECREASED | 781 | |
| 20 | MYELODYSPLASTIC SYNDROME | 763 | |
| 21 | FATIGUE | 743 | |
| 22 | DISEASE PROGRESSION | 640 | |
| 23 | VOMITING | 618 | |
| 24 | ASTHENIA | 604 | |
| 25 | HAEMOGLOBIN DECREASED | 604 | |
| 26 | SEPTIC SHOCK | 600 | |
| 27 | ACUTE MYELOID LEUKAEMIA RECURRENT | 582 | |
| 28 | CONSTIPATION | 554 | |
| 29 | CYTOPENIA | 550 | |
| 30 | DYSPNOEA | 465 |
Important Disclaimer
FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.